加载中
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
常规交易时段
US$12.10
+US$0.64 · +5.58%
盘中时间采用ET。市场数据可能有所延迟。
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
日内区间
当前US$12.10
52周区间
当前US$12.10
盘中时间采用ET。市场数据可能有所延迟。
BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets. Its primary offering is the Deep Transcranial Magnetic Stimulation (dTMS) platform technology, which provides treatment for various ailments including major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post-stroke rehabilitation, and Parkinson's disease. BrainsWay's clientele primarily comprises medical professionals, hospitals, and medical centers specializing in psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
日内区间
当前US$12.10
52周区间
当前US$12.10
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 5222.5万 USD | 4101.6万 USD | 3178.5万 USD | 2717.7万 USD | 2965.7万 USD |
| 销货成本 | 1283.9万 USD | 1043.5万 USD | 830.8万 USD | 712.9万 USD | 659.9万 USD |
| 毛利 | 3938.6万 USD | 3058.1万 USD | 2347.7万 USD | 2004.8万 USD | 2305.8万 USD |
| 研究与开发 | 960.3万 USD | 719万 USD | 666.5万 USD | 767.8万 USD | 639.3万 USD |
| 销售、一般及管理费用 | 2546万 USD | 2200万 USD | 2163.8万 USD | 2505.3万 USD | 2166.4万 USD |
| 营业费用 | 3506.3万 USD | 2919万 USD | 2843.6万 USD | 3273.1万 USD | 2805.7万 USD |
| 利息收入 | 564.04万 USD | 247.7万 USD | 217.1万 USD | 110.9万 USD | 22.5万 USD |
| 利息支出 | 222.65万 USD | 135.6万 USD | 29.8万 USD | 6.8万 USD | 14.1万 USD |
| 折旧和摊销 | 153.8万 USD | 177.1万 USD | 133.7万 USD | 153.4万 USD | 168.6万 USD |
| 营业利润 | 432.3万 USD | 139.1万 USD | −495.9万 USD | −1268.3万 USD | −499.9万 USD |
| 净利润 | 763.3万 USD | 292.1万 USD | −419.7万 USD | −1334.9万 USD | −646.2万 USD |
公司数据更新于 2026年10月13日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$19.50
上涨空间 61.16%| 行动 | 生效日期 | 详情 | 记录日期 | 付款日期 |
|---|---|---|---|---|
股票拆分 | 2026年3月4日 | 2:1 | — | — |
已生效 2026年3月4日
2:1
报告持有此股票敞口的交易所交易基金。
ARK Israel Innovative Technology ETFIZRL168.29万1.29%1.34亿 USD0.49%US$28.05+0.37%
Amplify BlueStar Israel Technology ETFITEQ82.95万0.78%1.06亿 USD0.75%US$60.66760.00%
ActivePassive International Equity ETFAPIE20.1万0.02%11.36亿 USD0.45%US$38.53+0.34%
Even Herd Long Short ETFEHLS17.64万0.30%5811万 USD2.62%US$25.355-0.10%
iShares Neuroscience and Healthcare ETFIBRN4.1万0.65%635.78万 USD0.47%US$31.430.00%
Defiance Autism Impact ETFASD2.9万2.19%132.35万 USD0.79%US$26.45-0.66%ARK Israel Innovative Technology ETFIZRLAmplify BlueStar Israel Technology ETFITEQActivePassive International Equity ETFAPIEEven Herd Long Short ETFEHLSiShares Neuroscience and Healthcare ETFIBRNDefiance Autism Impact ETFASDAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
